An underground market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Express Worries
However, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users administering products of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Material Elimination
According to the social media company, the service has removed problematic content and banned associated hashtags and search suggestions. The company stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Online Marketplace Operations
Research also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.
Within moments of joining one community, a vendor posted contact information, where most purchases take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, health issues or past usage.
Product Details and Costs
Within these groups, posts show black plastic parcels with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly significant health risks”.
